Invasive pneumococcal disease in Indian adults: 11 years ’ experience

Conclusion Serotype data from this study helped in accurate estimation of PCV-13 and PPV-23 protective coverage against serotypes causing IPD in India as 58.7% (95% CI: 53.8, 63.4) and 67.4% (95% CI: 62.7, 71.8) respectively. Penicillin non-susceptibility in meningeal IPD cases is 27.4%. Empirical therapy for meningeal IPD must be cephalosporin in combination with vancomycin since cefotaxime non-susceptibility in meningeal IPD is 9.9%.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research